LHC Group, Inc. (LHCG) Receives Consensus Rating of “Buy” from Analysts

Shares of LHC Group, Inc. (NASDAQ:LHCG) have received an average rating of “Buy” from the thirteen brokerages that are currently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $76.89.

A number of brokerages recently weighed in on LHCG. SunTrust Banks reissued a “buy” rating and issued a $75.00 price objective on shares of LHC Group in a research note on Friday, November 3rd. Oppenheimer raised their price objective on LHC Group from $68.00 to $80.00 and gave the company an “outperform” rating in a research note on Tuesday, November 7th. Royal Bank of Canada raised their price objective on LHC Group from $70.00 to $81.00 and gave the company an “outperform” rating in a research note on Tuesday, November 7th. Craig Hallum reaffirmed a “buy” rating and issued a $80.00 price target (up from $67.00) on shares of LHC Group in a research report on Tuesday, November 7th. Finally, Jefferies Group lifted their price target on LHC Group from $68.00 to $83.00 and gave the stock a “buy” rating in a research report on Tuesday, November 7th. They noted that the move was a valuation call.

Shares of LHC Group (NASDAQ LHCG) traded down $0.32 during trading on Tuesday, hitting $63.07. The stock had a trading volume of 152,666 shares, compared to its average volume of 261,914. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.24. LHC Group has a fifty-two week low of $47.29 and a fifty-two week high of $76.14. The firm has a market cap of $1,159.10, a price-to-earnings ratio of 27.19, a price-to-earnings-growth ratio of 1.64 and a beta of 0.71.

Several large investors have recently made changes to their positions in LHCG. Cubist Systematic Strategies LLC boosted its stake in LHC Group by 758.0% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 1,716 shares of the health services provider’s stock valued at $116,000 after buying an additional 1,516 shares in the last quarter. LS Investment Advisors LLC boosted its stake in LHC Group by 249.5% in the 4th quarter. LS Investment Advisors LLC now owns 2,478 shares of the health services provider’s stock valued at $152,000 after buying an additional 1,769 shares in the last quarter. SG Americas Securities LLC acquired a new stake in LHC Group in the 3rd quarter valued at $163,000. Jefferies Group LLC acquired a new stake in LHC Group in the 4th quarter valued at $200,000. Finally, Piedmont Investment Advisors LLC acquired a new stake in LHC Group in the 2nd quarter valued at $220,000. 83.00% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION NOTICE: This story was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.dispatchtribunal.com/2018/02/20/lhc-group-inc-lhcg-receives-consensus-rating-of-buy-from-analysts.html.

LHC Group Company Profile

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply